An observational, prospective, cohort study was performed to assess changes in insulin sensitivity and serum leptin level after a switch from a ritonavir-boosted PI (PI/r) to raltegravir or dolutegravir in HIV-infected adults on stable combination ART (cART).
Calza, L., Colangeli, V., Borderi, M., Coladonato, S., Tazza, B., Bon, I., et al. (2019). Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74(13), 731-738 [10.1093/jac/dky507].
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients
Calza, Leonardo;Colangeli, Vincenzo;Coladonato, Simona;Tazza, Beatrice;Bon, Isabella;Re, Maria Carla;Viale, Pierluigi
2019
Abstract
An observational, prospective, cohort study was performed to assess changes in insulin sensitivity and serum leptin level after a switch from a ritonavir-boosted PI (PI/r) to raltegravir or dolutegravir in HIV-infected adults on stable combination ART (cART).File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
